Case by Case: Optimizing Dual Immune Checkpoint Inhibitor Combination Therapies in Advanced Driver-Negative Non–Small Cell Lung Cancer
MP3•Episode home
Manage episode 433877222 series 3381434
Content provided by ReachMD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ReachMD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
CME credits: 1.50
Valid until: 17-07-2025
Claim your CME credit at https://reachmd.com/programs/cme/case-by-case-optimizing-dual-immune-checkpoint-inhibitor-combination-therapies-in-advanced-driver-negative-nonsmall-cell-lung-cancer/24418/
Struggling to navigate the latest immunotherapy options for advanced NSCLC? This online CME program delves into optimizing dual immune checkpoint inhibitor therapy for patients with driver-negative advanced NSCLC. Learn how to leverage recent clinical trial data and patient characteristics to individualize treatment for the best possible outcomes, including for those with challenging brain metastases.=
…
continue reading
Valid until: 17-07-2025
Claim your CME credit at https://reachmd.com/programs/cme/case-by-case-optimizing-dual-immune-checkpoint-inhibitor-combination-therapies-in-advanced-driver-negative-nonsmall-cell-lung-cancer/24418/
Struggling to navigate the latest immunotherapy options for advanced NSCLC? This online CME program delves into optimizing dual immune checkpoint inhibitor therapy for patients with driver-negative advanced NSCLC. Learn how to leverage recent clinical trial data and patient characteristics to individualize treatment for the best possible outcomes, including for those with challenging brain metastases.=
607 episodes